P115 Does trastuzumab increase ONJ development due to zoledronic acid treatment in breast cancer? von Pilanci, K.N, Alco, G, Ordu, C, Celebi, F, Sarsenov, D, Iyigun, Z. Erdogan, Agacayak, F, Ilgun, S, Ozmen, V

Volltext

254P - Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prosp... von Ordu, C., Gachayev, F., Elbuken, F., Baysal, B., Pilanci, K.N., Alco, G., Ilgun, A.S., Ucuncu, M., Ozturk, A., Erdogan, Z., Agacayak, F., Ozdem, G., Kayan, T., Uyar, T., Hocaoğlu, E., Soybir, G., Aktepe, F., Ozmen, V.

Volltext

Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective... von Ordu, C., Gachayev, F., Elbuken, F., Baysal, B., Pilanci, K.N., Alco, G., Ilgun, A.S., Ucuncu, M., Ozturk, A., Erdogan, Z., Agacayak, F., Ozdem, G., Kayan, T., Uyar, T., Hocaoğlu, E., Soybir, G., Aktepe, F., Ozmen, V.

Volltext

284PDO YOUNG AGE AND TRIPLE NEGATIVE MOLECULAR SUBTYPE HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH EARLY STAGE BREAST CANCER? von Ordu, C., Bozdogan, A., Alco, G., Pilanci, K.N., Selamoglu, D., Agacayak, F., Erdogan, Z., Ilgun, S., Elbuken, F., Igdem, S., Okkan, S., Ozmen, V.

Volltext

Do Young Age and Triple Negative Molecular Subtype Have a Negative Effect on Survival in Patients with Early Stage Breast Cancer? von Ordu, C., Bozdogan, A., Alco, G., Pilanci, K.N., Selamoglu, D., Agacayak, F., Erdogan, Z., Ilgun, S., Elbuken, F., Igdem, S., Okkan, S., Ozmen, V.

Volltext

The prognostic impact of chemotherapy induced amenorrhea in women treated with early stage breast cancer von Ordu, C., Pilancı, K.N., Elbüken, F., Alço, G., Köksal, Ü.İ., İlgün, S., Sarsenov, D., Aydın, A.E., Öztürk, A., Erdoğan, Z.İ., Ağaçayak, F., Tecimer, C., Eralp, Y., Aktepe, F., Özmen, V.

Volltext